Applications of array technology: identification of molecular targets in bladder cancer

High-throughput microarrays are being used in expression profiling analyses with the objecties of gene and pathway discovery, functional characterization of genes, and tumor subclassification. This review summarizes bladder cancer studies dealing with both in vitro models and clinical specimens, using distinct microarray platforms for target discovery.

• Publication year

  2003

• Venue

  British Journal of Cancer

• Publication date

  2003-12-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjc.6601406PMID 14676790PMCID 2395269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the Na,K‐ATPase α‐ and β‐subunit expression profiles of bladder cancer using tissue microarrays

  2003cited by this paper
• Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays.

  2003cited by this paper
• Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.

  2003cited by this paper
• Identifying distinct classes of bladder carcinoma using microarrays

  2003cited by this paper
• Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome.

  2003influential reference
• Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine.

  2002influential reference
• Tissue microarray analysis of cytoskeletal actin‐associated biomarkers gelsolin and E‐cadherin in urothelial carcinoma

  2002cited by this paper
• Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.

  2002cited by this paper
• Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.

  2002influential reference
• Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays.

  2002influential reference
• Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.

  2002influential reference
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Microarrays of cells expressing defined cDNAs

  2001cited by this paper
• Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF

  2001cited by this paper
• Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions

  2001cited by this paper
• Identification of gene expression patterns in superficial and invasive human bladder cancer.

  2001influential reference
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Microarray Profiling of Gene Expression Patterns in Bladder Tumor Cells Treated with Genistein

  2001influential reference
• Applications of peptide arrays prepared by the SPOT-technology.

  2001cited by this paper
• Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

  2001cited by this paper
• Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays.

  2000cited by this paper
• Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions

  2000cited by this paper
• High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.

  2000cited by this paper
• Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.

  2000cited by this paper
• Printing proteins as microarrays for high-throughput function determination.

  2000cited by this paper
• High density synthetic oligonucleotide arrays

  1999cited by this paper
• Tissue microarrays for gene amplification surveys in many different tumor types.

  1999cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• Mutational analysis using oligonucleotide microarrays

  1999cited by this paper
• Expression profiling using cDNA microarrays

  1999cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

  1998influential reference
• Use of a cDNA microarray to analyse gene expression patterns in human cancer

  1996cited by this paper
• Copyright © American Society for Investigative Pathology Gene Discovery in Bladder Cancer Progression using cDNA Microarrays

  year unknowninfluential reference

• Stimulus-Responsive Sequential Release Systems for Drug and Gene Delivery.

  2020cites this paper
• Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.

  2020cites this paper
• Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells.

  2019cites this paper
• MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways

  2016cites this paper
• Emerging Bladder Cancer Biomarkers and Targets of Therapy.

  2016cites this paper
• Molecular markers in bladder cancer: Novel research frontiers

  2015cites this paper
• Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways

  2014cites this paper
• Clinical Applications of Recent Molecular Advances in Urologic Malignancies: No Longer Chasing a “Mirage”?

  2013cites this paper
• Transcriptomic approaches to toxicity assessment

  2013cites this paper
• Molecular targets on the horizon for kidney and urothelial cancer

  2013cites this paper
• [Non-invasive diagnosis bladder cancer: new molecular markers and future perspectives].

  2013cites this paper
• Molecular genetics and genomics progress in urothelial bladder cancer.

  2013cites this paper
• Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

  2012cites this paper
• Molecular Pathology of Bladder Cancer.

  2012cites this paper
• Emerging critical role of molecular testing in diagnostic genitourinary pathology.

  2012cites this paper
• KISS-1 inhibits the proliferation and invasion of gastric carcinoma cells.

  2012cites this paper
• Emerging therapies for urothelial cancer.

  2012cites this paper
• Hypermethylation in bladder cancer: biological pathways and translational applications

  2012cites this paper
• Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer

  2012cites this paper
• Molecular Nomograms for Predicting Prognosis and Treatment Response

  2011cites this paper
• What are the expected developments in the medical treatment of bladder cancer.

  2011cites this paper
• PRACTICAL & CONTROVERSIAL ISSUES IN DIAGNOSIS , GRADING AND STAGING OF UROTHELIAL CARCINOMA : AN APPROACH

  2011cites this paper
• Transcriptional profile of diuron-induced toxicity on the urinary bladder of male Wistar rats to inform mode of action.

  2011cites this paper
• Molecular diagnostics in urologic malignancies: a work in progress.

  2011cites this paper
• Chapter 16 – Immunohistology of the Prostate, Bladder, Kidney, and Testis

  2011cites this paper
• Gene Expression Signature in Urine for Diagnosing and Assessing Aggressiveness of Bladder Urothelial Carcinoma

  2010cites this paper
• Theranostic and prognostic biomarkers: genomic applications in urological malignancies.

  2010cites this paper
• Proteomic study of sera from patients with bladder cancer: usefulness of S100A8 and S100A9 proteins.

  2010cites this paper
• Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer

  2010cites this paper
• 9and Significance of Micrometastases

  2010cites this paper
• Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agents.

  2009cites this paper
• Presence and Significance of Micrometastases

  2009cites this paper
• Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.

  2009cites this paper
• Guidelines for development of diagnostic markers in bladder cancer

  2008cites this paper
• Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis

  2008cites this paper
• Promotion of bladder cancer development and progression by androgen receptor signals.

  2007cites this paper
• Discovering gene-gene relations from sequential sentence patterns in biomedical literature

  2007cites this paper
• Chemotherapy for metastatic or unresectable bladder cancer.

  2007cites this paper
• Yüzeyel Mesane Tümörlerinde Tanısal ve Prognostik Yeni Belirleyiciler

  2006cites this paper
• Novel Diagnostic Markers and Prognosticators in Superficıal Bladder Cancer

  2006cites this paper
• The Effect of Cyclooxygenase-2 Inhibitor on the Gene Expression Profile of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced Rat Urinary Bladder Cancer

  2006cites this paper
• Molecular Biomarkers for Cancer Detection in Blood and Bodily Fluids

  2006cites this paper
• Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis

  2006cites this paper
• Gene Expression Analysis and Genetic Studies in Multiple Sclerosis

  2005cites this paper
• Mutations of tumour suppressor gene P 53 ( TP 53 ) in tumour tissue and cellular urine sediments in urinary bladder cancer

  2005cites this paper
• Loss of Expression of the Adipocyte-type Fatty Acid-binding Protein (A-FABP) Is Associated with Progression of Human Urothelial Carcinomas*

  2005cites this paper
• The promise of gene‐expression analysis in bladder cancer: a clinician's guide

  2005cites this paper
• Head and Neck

  2005cites this paper
• Molecular pathogenesis of Helicobacter hepaticus induced liver disease

  2005cites this paper
• Gene Expression Analysis in Pharmacogenetics and Pharmacogenomics

  2005cites this paper
• Antisense oligonucleotide therapy in the management of bladder cancer

  2005cites this paper
• Global Gene Expression Profiling: A Complement to Conventional Histopathologic Analysis of Neoplasia

  2005cites this paper
• Using RNAi to catch Drosophila genes in a web of interactions: insights into cancer research

  2004cites this paper
• Discovering gene-gene relations from fuzzy sequential sentence patterns in biomedical literature

  2004cites this paper
• Impact of proteomics on bladder cancer research.

  2004cites this paper
• Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?)

  2004cites this paper
• FACTORES PRONÓSTICOS MOLECULARES EN CÁNCER DE VEJIGA

  2004cites this paper